Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/20436269

Download in:

View as

General Info

PMID
20436269